Live from the NIH registry
Studies recruiting near Santa Ana right now
Top 25 of 1,961 recruiting studies, sorted by proximity — each links to its official registry page
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Multiple conditions
N/A
Observational 4,000 participants sought
Congenital Muscle Disease International Registry (www.cmdir.org) — Lakewood, California (16.6 mi)
· Sponsor: Cure CMD
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
Children's Hospital Orange County — Orange, California (3.9 mi)
· Sponsor: New York Medical College
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma
Phase 1
Interventional 46 participants sought
City of Hope Medical Foundation — Duarte, California (28.4 mi)
· Sponsor: SciTech Development, Inc.
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) — Orange, California (3.9 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Orange County — Orange, California (3.9 mi)
· Sponsor: National Cancer Institute (NCI)
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
Spinal Cord Injury, Pressure Injury
N/A
Interventional 808 participants sought
VA Long Beach Healthcare System, Long Beach, CA — Long Beach, California (17.8 mi)
· Sponsor: VA Office of Research and Development
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
City of Hope Comprehensive Cancer Center ( Site 0191) — Duarte, California (28.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
City of Hope National Medical Center — Duarte, California (28.4 mi)
· Sponsor: Relay Therapeutics, Inc.
Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke
Chronic Stroke Patients
N/A
Interventional 32 participants sought
University of California Irvine — Irvine, California (5.7 mi)
· Sponsor: University of California, Irvine
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Non-segmental Vitiligo
Phase 2
Interventional 45 participants sought
Marvel Clinical Research — Huntington Beach, California (8.6 mi)
· Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retina Associates of Southern California — Huntington Beach, California (8.6 mi)
· Sponsor: Boehringer Ingelheim
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 78 participants sought
City of Hope Medical Center — Duarte, California (28.4 mi)
· Sponsor: City of Hope Medical Center
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
University of California - Irvine — Irvine, California (5.7 mi)
· Sponsor: AskBio Inc
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
Alzheimer Disease
Phase 1
Interventional 18 participants sought
Hoag Memorial Hospital Presbyterian — Newport Beach, California (8.6 mi)
· Sponsor: Regeneration Biomedical, Inc.
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Necrotizing Soft Tissue Infection
N/A
Observational 50 participants sought
University of California Irvine Medical Center — Orange, California (3.9 mi)
· Sponsor: University of California, Irvine
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 226 participants sought
Research Site — Irvine, California (5.7 mi)
· Sponsor: AstraZeneca
MiGo Tracker Remote Monitoring of Home Exercise After Stroke
Subacute Stroke
N/A
Interventional 50 participants sought
Rancho Research Institute, Inc — Downey, California (20.1 mi)
· Sponsor: Flint Rehabilitation Devices, LLC
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Irvine, California (5.7 mi)
· Sponsor: AstraZeneca
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
First OC Dermatology Research — Fountain Valley, California (4.5 mi)
· Sponsor: Takeda
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Southern California Permanente Medical Group — Bellflower, California (16.8 mi)
· Sponsor: Mirati Therapeutics Inc.
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
City of Hope ( Site 0014) — Duarte, California (28.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Prostate Cancer
Phase 2
Interventional 184 participants sought
Hoag Memorial Hospital Presbyterian — Irvine, California (5.7 mi)
· Sponsor: Hoag Memorial Hospital Presbyterian
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Orange County Retina Med Group — Santa Ana, California (1.0 mi)
· Sponsor: Genentech, Inc.
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma
Phase 1
Interventional 694 participants sought
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589 — Irvine, California (5.7 mi)
· Sponsor: AbbVie
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
Advanced Cancer, Solid Tumor
Phase 1
Interventional 26 participants sought
City of Hope National Medical Center — Duarte, California (28.4 mi)
· Sponsor: Proviva Therapeutics, Inc.